{"id":51010,"date":"2022-11-17T19:02:54","date_gmt":"2022-11-17T18:02:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/"},"modified":"2022-11-17T19:02:54","modified_gmt":"2022-11-17T18:02:54","slug":"genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/","title":{"rendered":"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages"},"content":{"rendered":"
\n

\nThe first and only clean medicine company to deliver pain relievers and fever reducers with the same effective acetaminophen as category leaders, but without any artificial fillers, offers families a clean solution<\/i>\n<\/p>\n

ATLANTA–(BUSINESS WIRE)–Families concerned about rising respiratory syncytial virus (RSV) and flu cases in the United States have a new potential obstacle to worry about \u2013 what appears to be an emerging shortage of infants\u2019 and kids\u2019 pain relievers and fever reducers, which first impacted Canada<\/a> and now seems to be a growing concern in the United States.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nWhile demand for pain relievers and fever reducers typically increases during cold and flu season, there are growing concerns about the supply of infants\u2019 and kids\u2019 pain and fever medicines. As a result, Genexa<\/a>, the first and only clean medicine company founded in 2016, has been approached by major retailers asking for more of its clean pediatric acetaminophen products to meet increased demand that cannot be fulfilled by other brands.\n<\/p>\n

\nGenexa\u2019s Infants\u2019 and Kids\u2019 Pain & Fever medicines are made with the same effective acetaminophen as the leading brands, but are free of all artificial fillers including dyes, artificial sweeteners, and artificial preservatives. As fierce advocates for clean medicine, the brand is experiencing unprecedented growth due to increased demand and short supply from competitors, and is working with its retail partners and pediatricians across the country to call attention to the options consumers have with Genexa\u2019s clean acetaminophen products.\n<\/p>\n

\n\u201cWe want families to know we are here for them and have clean, effective infants\u2019 and kids\u2019 pain relievers and fever reducers that deliver the same, effective acetaminophen as other brands but without all the artificial inactive ingredients,\u201d said David Johnson, Genexa\u2019s CEO and Co-Founder. \u201cWe started Genexa because we wanted a clean choice for our families\u2014and for all families\u2014 it\u2019s just what people deserve. We\u2019re committed to keeping shelves stocked during this time as we continue to provide widespread access to our medicines.\u201d\n<\/p>\n

\nBecause Genexa\u2019s unique formulation does not rely on artificially derived inactive ingredients, it is not experiencing the shortages impacting traditional brands. In fact, on the heels of Genexa\u2019s Kids\u2019 Pain and Fever Chewable<\/a> launch, Genexa is ramping up production to give families and healthcare professionals viable options they can depend on \u2013 free of dyes, artificial sweeteners, artificial preservatives, all artificial inactive ingredients.\n<\/p>\n

\n\u201cMany of my patients are actively seeking out products without unnecessary artificial ingredients that are not only better suited for their lifestyles, but are thoughtfully made with situations like this in mind,\u201d said Shayna Smith, M.D., Pediatrician with Flourish Pediatrics in Sandy Springs, GA. \u201cI\u2019m grateful I can recommend products like Genexa\u2019s Infants\u2019 and Kids\u2019 Pain & Fever as effective, and widely available options people can turn to as other branded pain and fever medicines may become increasingly hard to find.\u201d\n<\/p>\n

\nGenexa\u2019s medicines span many categories of OTC treatment including cold and flu, analgesics, digestive and allergy for infants, kids, and adults. In their commitment to deliver a new standard of effective but also clean medicines to all, Genexa has created an Ex List,<\/a> a published list of unnecessary inactive ingredients the company vows to never use in their medicine, including artificial inactive ingredients like artificial dyes, talc, sorbitol, high fructose corn syrup, propylene glycol, titanium dioxide, and common allergens like gluten and lactose.\n<\/p>\n

\nGenexa products, including its Infants\u2019 and Kids\u2019 Pain & Fever medicines, can be found in 45,000 retailers nationwide, including Walgreens, CVS, Amazon, Rite Aid, and more. To find a retailer near you or for more information, visit Genexa.com<\/a> or follow us on social at @Genexa<\/a>.\n<\/p>\n

\nABOUT GENEXA
\n
<\/b>Founded in 2016 by two dads on a mission to revolutionize the medicine aisle, Genexa makes medicine with the same active ingredients people need, but without the artificial ones they don\u2019t. Genexa believes people deserve real choices. That\u2019s why their business is built on the commitment to put people over everything. All Genexa\u2019s products are made to the highest standards of medicine with no artificial dyes, common allergens, or unnecessary inactive ingredients. It\u2019s real medicine, made clean. With a commitment to innovation at every turn, Genexa was recently named to Fast Company\u2019s prestigious list of the World\u2019s Most Innovative Companies in 2022. Learn how Genexa is putting people over everything, in everything they do, at Genexa.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact:
\n
Superjuice on behalf of Genexa: Anna Cardelfe
\n
732.770.6167, anna@wearesuperjuice.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The first and only clean medicine company to deliver pain relievers and fever reducers with the same effective acetaminophen as category leaders, but without any artificial fillers, offers families a clean solution ATLANTA–(BUSINESS WIRE)–Families concerned about rising respiratory syncytial virus (RSV) and flu cases in the United States have a new potential obstacle to worry … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51010","6":"format-standard","7":"category-industry"},"yoast_head":"\nGenexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The first and only clean medicine company to deliver pain relievers and fever reducers with the same effective acetaminophen as category leaders, but without any artificial fillers, offers families a clean solution ATLANTA–(BUSINESS WIRE)–Families concerned about rising respiratory syncytial virus (RSV) and flu cases in the United States have a new potential obstacle to worry ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-17T18:02:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221117006011\/en\/1641915\/21\/Genexa_Business_Wire_Image_v2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages\",\"datePublished\":\"2022-11-17T18:02:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/\"},\"wordCount\":758,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117006011\\\/en\\\/1641915\\\/21\\\/Genexa_Business_Wire_Image_v2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/\",\"name\":\"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117006011\\\/en\\\/1641915\\\/21\\\/Genexa_Business_Wire_Image_v2.jpg\",\"datePublished\":\"2022-11-17T18:02:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117006011\\\/en\\\/1641915\\\/21\\\/Genexa_Business_Wire_Image_v2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221117006011\\\/en\\\/1641915\\\/21\\\/Genexa_Business_Wire_Image_v2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/","og_locale":"en_US","og_type":"article","og_title":"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages - Pharma Trend","og_description":"The first and only clean medicine company to deliver pain relievers and fever reducers with the same effective acetaminophen as category leaders, but without any artificial fillers, offers families a clean solution ATLANTA–(BUSINESS WIRE)–Families concerned about rising respiratory syncytial virus (RSV) and flu cases in the United States have a new potential obstacle to worry ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-17T18:02:54+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221117006011\/en\/1641915\/21\/Genexa_Business_Wire_Image_v2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages","datePublished":"2022-11-17T18:02:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/"},"wordCount":758,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221117006011\/en\/1641915\/21\/Genexa_Business_Wire_Image_v2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/","url":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/","name":"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221117006011\/en\/1641915\/21\/Genexa_Business_Wire_Image_v2.jpg","datePublished":"2022-11-17T18:02:54+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221117006011\/en\/1641915\/21\/Genexa_Business_Wire_Image_v2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221117006011\/en\/1641915\/21\/Genexa_Business_Wire_Image_v2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/genexa-provides-clean-and-effective-infants-and-kids-pain-and-fever-reducers-in-light-of-impending-shortages\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Genexa Provides Clean and Effective Infants\u2019 and Kids\u2019 Pain and Fever Reducers in Light of Impending Shortages"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51010","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51010"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51010\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}